乳腺癌放射治疗中靶区与危及器官勾画的变异性:POTENTIAL 试验预试验基准案例的质量保证结果
该研究为 POTENTIAL 试验(多中心、随机、3 期、评估高危乳腺癌乳房切除术后放疗联合或不联合内乳淋巴结照射)质量保证项目的一部分,将基准案例的模拟 CT 数据集发送至参与中心,要求研究者按方案指南勾画临床靶区(CTV)和危及器官,并与质量保证团队参考勾画进行定量几何分析。结果显示胸壁、对侧乳腺和心脏的勾画变异较小,而内乳淋巴结区、同侧臂丛、左前降支冠状动脉和右冠状动脉变异显著;结论指出尽管提供了详细方案仍存在残余勾画变异,确认了预试验质量保证的重要性,并强调需要对靶区勾画进行教育和考虑实时中心审核。
要点
- 26 个中心提交的勾画与参考勾画之间存在变异。
- 胸壁、对侧乳腺和心脏的平均 JCI 分别为 0.62、0.68 和 0.87,变异较小。
- 内乳淋巴结区、同侧臂丛、左前降支冠状动脉和右冠状动脉的平均 JCI 分别为 0.38、0.21、0.29 和 0.18,提示显著变异。
核心结论
- 尽管提供了详细方案,仍存在残余勾画变异,确认了放疗预试验质量保证的重要性,并强调需要对靶区勾画进行教育和考虑在试验参与者开始放疗前进行实时中心审核。
研究设计与样本
- POTENTIAL 试验质量保证项目的一部分,将基准案例的模拟 CT 数据集发送至参与中心,要求研究者按方案指南勾画临床靶区和危及器官,共审查了 26 个中心提交的勾画。
主要发现
- 胸壁、对侧乳腺和心脏的临床靶区平均 JCI 分别为 0.62、0.68 和 0.87,变异较小。
- 内乳淋巴结区、同侧臂丛、左前降支冠状动脉和右冠状动脉的临床靶区平均 JCI 分别为 0.38、0.21、0.29 和 0.18,提示显著变异。
- 在 CTVsc + axIII + axII 的逐层分析中,4 个层面上发现明显的勾画不足和过度勾画变异。
关键数值与推荐
- 定量几何分析指标包括体积、Jaccard 指数(JCI)、Dice 相似系数、地理遗漏指数、不一致指数和平均一致距离。
- 除对所有结构进行全体积分析外,还对锁骨上窝与 III 区和 II 区腋窝的组合勾画(CTVsc + axIII + axII)进行逐层分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To estimate the variations in clinical target volumes (CTVs) and organs at risk delineation within the quality assurance (QA) program of the POTENTIAL trial, which is a multicenter, randomized phase 3 trial evaluating postmastectomy radiation therapy (RT), with or without internal mammary nodal irradiation, for patients with high-risk breast cancer. METHODS AND MATERIALS: The simulating computed tomography scan data set of a benchmark case was sent to the participating centers, and the delineation of CTVs and organs at risk was required to be completed by the investigators following protocol guidelines. All submitted contours were reviewed and compared with the reference contours created by the QA team, using quantitative geometric analysis regarding volume and the Jaccard Index (JCI), Dice similarity coefficient, Geographic Miss Index, Discordance Index, and mean distance to agreement. In addition to the whole-volume analysis of all structures, the combination contour of the supraclavicular fossa and level III and II axilla (CTVsc + axIII + axII) was further analyzed on a slice-by-slice basis. RESULTS: The contours from 26 centers were reviewed and variations were observed between submission and reference. The variations of the CTV of the chest wall, contralateral breast, and heart were small, for which the mean JCI values were 0.62, 0.68, and 0.87, respectively. However, the mean JCI values of the CTV of the internal mammary nodal region, ipsilateral brachial plexus, left anterior descending coronary artery, and right coronary artery were 0.38, 0.21, 0.29, and 0.18, respectively, suggesting marked variations. In addition, marked under- and overoutlining variations were identified on 4 slices of CTVsc + axIII + axII on slice-by-slice analysis. CONCLUSIONS: There were residual contouring variations despite a detailed protocol being provided, confirming the importance of pretrial QA in RT and highlighting the need for education and consideration of a real-time central review of the target delineation before the trial participants begin RT.
引用
- Song YC, Yan XN, Tang Y, et al. Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial. Pract Radiat Oncol. 2022. PMID: 36058618. doi:10.1016/j.prro.2021.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。